New global programme funded to target COVID-19 neurological disease

(University of Liverpool) The University of Liverpool is leading a new global project to better understand how and why COVID-19 affects the brain in order to develop measures to help improve patient outcomes. The University has secured £860,000 from the National Institute for Health Research (NIHR), in partnership with UK Research and Innovation (UKRI) to establish the COVID-Neuro Global programme in partnership with five leading research organisations in Brazil, India and Malawi.